Dubois-Stringfellow Nathalie (CIK 0001947007)

Latest company ownership

SGMO - SANGAMO THERAPEUTICS, INC
Role: SVP-CHIEF DEVELOPMENT OFFICER
Shares held
719,804
Last filed at
Nov 26, 2025
Confidence Score
49.2
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 24, 2025 Nov 26, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 52.5 -2,544 -0.35% ✗ $1.1K
Oct 22, 2025 Oct 24, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 46.3 -43,741 -5.71% ✗ $28.9K
Aug 24, 2025 Aug 26, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 52.5 -1,792 -0.23% ✗ $1.1K
Jul 22, 2025 Jul 24, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 46.3 -31,866 -3.98% ✗ $15.3K
May 24, 2025 May 28, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 52.5 -1,792 -0.22% ✗ $848.2
Apr 22, 2025 Apr 24, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 46.3 -31,866 -3.82% ✗ $24.7K
Feb 24, 2025 Feb 26, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 90.0 +116,695 16.28% ✗ $3.2K
Jan 22, 2025 Jan 24, 2025 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 42.5 -129,593 -15.31% ✗ $149K
Nov 24, 2024 Nov 26, 2024 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 52.5 -3,295 -0.39% ✗ $6.3K
Aug 24, 2024 Aug 27, 2024 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 52.5 -3,295 -0.39% ✗ $2.8K
May 24, 2024 May 29, 2024 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 52.5 -3,295 -0.39% ✗ $2K
Feb 24, 2024 Feb 27, 2024 SANGAMO THERAPEUTICS, INC SVP-CHIEF DEVELOPMENT OFFICER Sell 46.3 -10,484 -1.22% ✗ $11.8K
Nov 25, 2023 Nov 28, 2023 SANGAMO THERAPEUTICS, INC SVP-Chief Development Officer Sell 47.5 -1,462 -1.04% ✗ $558.6
Aug 25, 2023 Aug 29, 2023 SANGAMO THERAPEUTICS, INC SVP-Chief Development Officer Sell 47.5 -1,462 -1.03% ✗ $1.1K
May 25, 2023 May 30, 2023 SANGAMO THERAPEUTICS, INC SVP-Chief Development Officer Sell 47.5 -1,462 -1.06% ✗ $1.9K
Feb 24, 2023 Mar 6, 2023 SANGAMO THERAPEUTICS, INC SVP-Chief Development Officer Sell 91.3 +43,604 45.92% ✗ $26.2K